New technology proves effective at assessing myoclonic jerks in EPM1

Written by Darcy Hodge, Editor

Myography HTA Myoclonic jerks

As part of an initiative to encourage technological advances for patients with rare diseases, the University of Eastern Finland has recently developed new technology to assess myoclonic jerks in myoclonic epilepsy type one (EPM1) patients. Published in Clinical Neurophysiology, the researchers highlight the use of novel sensory methods to investigate the severity of myoclonic jerks. The wearable sensor, worn on the non-dominant arm, operated using surface electromyography to detect electrical activity in the muscle due to myoclonic jerks.  These jerks are sudden movements that are potentially activated by movement or alternative stimuli. They are also subject to variation, as they can be classified as positive, a sudden muscle contraction, or negative, the loss of muscle activation.  Past methods of investigating myoclonic jerks include clinic visits...

To view this content, please register now for access

It's completely free